CA2428443A1 - Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe - Google Patents

Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe Download PDF

Info

Publication number
CA2428443A1
CA2428443A1 CA002428443A CA2428443A CA2428443A1 CA 2428443 A1 CA2428443 A1 CA 2428443A1 CA 002428443 A CA002428443 A CA 002428443A CA 2428443 A CA2428443 A CA 2428443A CA 2428443 A1 CA2428443 A1 CA 2428443A1
Authority
CA
Canada
Prior art keywords
sars
nsp1
nsp9
nsp10
nsp12
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002428443A
Other languages
English (en)
Inventor
Michel Houde
Jean-Michel Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaltis Inc
Original Assignee
Adaltis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaltis Inc filed Critical Adaltis Inc
Priority to CA002428443A priority Critical patent/CA2428443A1/fr
Priority to CA002441677A priority patent/CA2441677A1/fr
Priority to CA002524609A priority patent/CA2524609A1/fr
Priority to PCT/CA2004/000672 priority patent/WO2004099240A2/fr
Priority to EP04731120A priority patent/EP1622932A2/fr
Priority to US10/556,204 priority patent/US20060263765A1/en
Priority to CNA2004800195752A priority patent/CN1820021A/zh
Publication of CA2428443A1 publication Critical patent/CA2428443A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002428443A 2003-05-09 2003-05-09 Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe Abandoned CA2428443A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002428443A CA2428443A1 (fr) 2003-05-09 2003-05-09 Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe
CA002441677A CA2441677A1 (fr) 2003-05-09 2003-09-23 Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe
CA002524609A CA2524609A1 (fr) 2003-05-09 2004-05-05 Peptides et certains de leurs melanges convenant a la detection du coronavirus associe au syndrome respiratoire aigu severe (sras)
PCT/CA2004/000672 WO2004099240A2 (fr) 2003-05-09 2004-05-05 Peptides et certains de leurs melanges convenant a la detection du coronavirus associe au syndrome respiratoire aigu severe (sras)
EP04731120A EP1622932A2 (fr) 2003-05-09 2004-05-05 Peptides et certains de leurs melanges convenant a la detection du coronavirus associe au syndrome respiratoire aigu severe (sras)
US10/556,204 US20060263765A1 (en) 2003-05-09 2004-05-05 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
CNA2004800195752A CN1820021A (zh) 2003-05-09 2004-05-05 用于检测与严重的急性呼吸综合征(sars)相关的冠状病毒的肽及其混合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002428443A CA2428443A1 (fr) 2003-05-09 2003-05-09 Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe

Publications (1)

Publication Number Publication Date
CA2428443A1 true CA2428443A1 (fr) 2004-11-09

Family

ID=33426227

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002428443A Abandoned CA2428443A1 (fr) 2003-05-09 2003-05-09 Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe

Country Status (2)

Country Link
CN (1) CN1820021A (fr)
CA (1) CA2428443A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111426829A (zh) * 2020-03-13 2020-07-17 南京农业大学 一种检测SARS-CoV-2 IgM-IgG抗体总量的量子点微球免疫层析试纸条

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111153991A (zh) * 2020-02-26 2020-05-15 北京博奥森生物技术有限公司 一种人SARS-CoV-2单克隆抗体及其制备方法和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111426829A (zh) * 2020-03-13 2020-07-17 南京农业大学 一种检测SARS-CoV-2 IgM-IgG抗体总量的量子点微球免疫层析试纸条

Also Published As

Publication number Publication date
CN1820021A (zh) 2006-08-16

Similar Documents

Publication Publication Date Title
US5574132A (en) Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
Wolinsky et al. An antibody-and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain
EP0317804B1 (fr) Peptides de VIH et méthodes de détection de VIH
CA2441677A1 (fr) Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe
CA2086922C (fr) Peptides synthetiques et melanges les contenant utilises pour detecter les anticorps anti-vih
US5164481A (en) Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
ES2136653T5 (es) Polipeptidos de sintesis que pertenecen al virus de la hepatitis c (vhc), utilizables principalmente para la deteccion de este ultimo.
JP3390002B2 (ja) Ｈｔｌｖ―ｉおよびｈｔｌｖ―ｉｉウイルスに対する抗体を検出するためのペプチドおよびアナログおよびその混合物
JPH01224397A (ja) Ｈｉｖ抗体を検出するための合成ペプチド及びその混合物
Joisson et al. Detection of potyviruses with antisera to synthetic peptides
CA2428443A1 (fr) Peptides et melanges de peptides permettant de detecter des anticorps contre le coronavirus associe au syndrome respiratoire aigu severe
WO1991006562A1 (fr) Domaines immunologiques de l'antigene du virus delta de l'hepatite
US5427792A (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
US5359029A (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-I and HTLV-II viruses
US6218102B1 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
Ohshima et al. Production and characteristics of strain common antibodies against a synthetic polypeptide corresponding to the C-terminal region of potato virus Y coat protein
CA1341594C (fr) Peptides synthetiques et leur melanges pour la detection d'anticorps contre hiv

Legal Events

Date Code Title Description
FZDE Dead